| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |